GLP 3

GLP 3

Size: 30mg

$159.99

mg

Fast Shipping

Same-day processing with discreet, temperature-controlled delivery

Third-Party Tested

Every batch independently verified for purity and potency

99%+ Purity

HPLC-verified pharmaceutical grade research compounds

Product Description

Peptide Triple Agonist  – Research Use Only

Peptide Triple Agonist is a premium lyophilized peptide formulation designed exclusively for research and laboratory applications. This advanced triple agonist peptide is being studied for its interaction with multiple metabolic pathways, including GLP-1, GIP, and glucagon receptor activity, making it a subject of interest in modern peptide research.

Researchers study this class of peptides for its potential role in exploring:

  • Metabolic function and regulation
  • Energy expenditure and nutrient utilization
  • Appetite and satiety signaling pathways
  • Body composition and weight management mechanisms
  • Glucose and insulin response pathways

Product Details

  • Product Name: Peptide Triple Agonist
  • Concentration: 30mg per vial
  • Form: Lyophilized powder
  • Storage: Store refrigerated according to laboratory handling standards
  • Intended Use: Research use only

Important Notice

This product is intended solely for in vitro research, analytical, and educational purposes. It is not intended for human or veterinary use and is not approved to diagnose, treat, cure, or prevent any disease. Proper laboratory practices and handling procedures should always be followed.

99.2% Purity Rate HPLC-verified pharmaceutical grade
50K+ Orders Shipped Trusted by researchers worldwide
127+ 5-Star Reviews Verified customer feedback
24hr Avg Ship Time Same-day processing available

Important Notes

  • This product is intended for research and laboratory use only.
  • Must be handled by qualified research professionals.
  • Store in a cool, dry place away from direct sunlight.
  • Keep out of reach of children and unauthorized individuals.
  • Follow all applicable local regulations regarding research compounds.

Subscribe to our Newsletter

Subscribe to our newsletter to get daily insights, news, updates.